Kang Woo Seok, Kim Shin Ae, Yang Chan Joo, Nam Sung Hoon, Chung Jong Woo
a Department of Otorhinolaryngology-Head & Neck Surgery , Asan Medical Center, University of Ulsan College of Medicine , Seoul , South Korea.
Acta Otolaryngol. 2017 Apr;137(4):352-355. doi: 10.1080/00016489.2016.1255992. Epub 2016 Nov 25.
Middle fossa approach (MFA) shows a hearing preservation rate of 86% and facial nerve function was preserved with HB grade I or II in 93%. MFA is a good treatment option for intra-canalicular vestibular schwannomas when surgical excision is needed.
Surgical outcomes of vestibular schwannoma have progressively improved with the advancement of microsurgical instruments. MFA is known to have better chances to preserve hearing, while it has limited access to the posterior fossa, limitation of tumor size, and higher risk of post-operative facial nerve weakness.
To investigate surgical outcomes and clinical efficiency of MFA in vestibular schwannoma.
A retrospective study was done in 14 patients who underwent MFA for vestibular schwannoma in Asan Medical Center.
The median age at diagnosis was 46.3 years. At initial presentation, 57% of the patients had vertigo, 43% hearing disturbance, and 64% tinnitus. The mean tumor size was 9.7 mm. The tumors were completely resected in 86% of the patients. Hearing was post-operatively preserved in 12 patients and two patients lost their hearing following surgery. Facial nerve function post-operatively remained unchanged in 12 patients (86%).
中颅窝入路(MFA)的听力保留率为86%,93%的患者面神经功能得以保留,面神经功能分级为HB Ⅰ级或Ⅱ级。当需要手术切除时,MFA是治疗管内型前庭神经鞘瘤的良好选择。
随着显微外科器械的进步,前庭神经鞘瘤的手术效果逐步改善。已知MFA保留听力的机会更大,但其进入后颅窝的范围有限,对肿瘤大小有限制,且术后面神经麻痹的风险较高。
探讨MFA治疗前庭神经鞘瘤的手术效果及临床疗效。
对峨山医学中心14例行MFA治疗前庭神经鞘瘤的患者进行回顾性研究。
诊断时的中位年龄为46.3岁。初次就诊时,57%的患者有眩晕,43%有听力障碍,64%有耳鸣。肿瘤平均大小为9.7毫米。86%的患者肿瘤得以完全切除。术后12例患者听力得以保留,2例患者术后听力丧失。12例患者(86%)术后面神经功能无变化。